The analyst recommends Thermo Fisher Scientific as a potential beneficiary of pharmaceutical tariffs. Many of its lab tools and specialty chemicals are targeted by these tariffs, and increased domestic production would favor the company.
“Thermaloffisher Scientific, ticker TMO, would also benefit on its lab tools and specialty chemicals, many of which are also being targeted in the tariffs.”